Article Text

Download PDFPDF
Chronic lymphoedema: a nidus for squamous cell carcinoma
  1. Shrea Gulati1,
  2. Sheragaru Hanumanthappa Chandrashekhara1,
  3. Sandeep Bhoriwal2 and
  4. Snehal Ishwar Kose1
  1. 1Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, Delhi, India
  2. 2Surgical Oncology, AIIMS, New Delhi, Delhi, India
  1. Correspondence to Dr Sheragaru Hanumanthappa Chandrashekhara; drchandruradioaiims{at}gmail.com

Abstract

Lymphoedema is a chronic debilitating condition characterised by diffuse swelling caused by lymphatic obstruction. The secondary form of lymphoedema is more common than the primary form. Untreated filariasis remains an important cause of lymphoedema in developing countries. The most common complication of chronic lymphoedema is cellulitis. It is also a risk factor for the development of neoplasms such as lymphangiosarcoma, squamous cell carcinoma, melanoma, lymphoma and malignant fibrous histiocytoma. We report a case of a woman in her 60s who developed squamous cell carcinoma in the background of chronic lymphoedema.

  • Skin cancer
  • Dermatological

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors All authors contributed to data collection, analysis and manuscript preparation. SG, SHC: concept, design, reporting, data acquisition, data interpretation, writing of the manuscript. SB, SIK: data acquisition and interpretation, writing and editing of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.